|
End-of-day quote
Shanghai S.E.
17/08/2026
|
5-day change | 1st Jan Change | ||
| 4.990 CNY | -1.38% |
|
-1.19% | -2.54% |
| 29/07 | Jointown Pharmaceutical Plans Up to 2.2-Billion-Yuan Factoring | MT |
| 16/07 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| Market Cap | 2.49TCr 369.11Cr 318.66Cr 298.95Cr 272.29Cr 511.99Cr 35TCr 519.08Cr 3.5TCr 1.37TCr 18TCr 1.39TCr 1.36TCr 59TCr | P/E 2026 * |
10.8x | P/E 2027 * | 10x |
|---|---|---|---|---|---|
| Enterprise Value | 2.06TCr 305.02Cr 263.32Cr 247.04Cr 225Cr 423.08Cr 29TCr 428.94Cr 2.9TCr 1.13TCr 15TCr 1.15TCr 1.12TCr 49TCr | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.19% | Yield 2027 * | 4.46% |
| 1 day | -1.38% | ||
| 1 week | -1.19% | ||
| Current month | -3.11% | ||
| 1 month | -2.35% | ||
| 3 months | +0.81% | ||
| 6 months | -3.11% | ||
| Current year | -2.54% |
| 1 week | 4.91 |  | 5.15 |
| 1 month | 4.87 | | 5.23 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Hua Gong
CEO | Chief Executive Officer | 48 | 15/10/2024 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 15/11/2023 |
Wei He
CEO | Chief Executive Officer | 40 | 23/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 16/11/2008 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 05/11/2020 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 01/07/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/06/24 | Buy | Chief Executive Officer | 60,494 | 0.0015% | ||
| 07/06/24 | Buy | 3,025 | 0.0001% | |||
| 07/06/24 | Buy | Director | 1,210 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.38% | -1.19% | -6.55% | -9.06% | 369.11Cr | |
| -1.04% | -2.27% | +27.76% | +106.24% | 10TCr | |
| +0.21% | -0.64% | +57.52% | +172.79% | 5.48TCr | |
| -1.69% | -2.36% | +1.40% | +279.08% | 2.41TCr | |
| -0.72% | -1.50% | -12.44% | -15.93% | 818.55Cr | |
| -0.94% | -0.64% | -31.55% | -23.57% | 765.9Cr | |
| +0.65% | +0.48% | -12.65% | -20.24% | 668.27Cr | |
| -0.37% | +3.47% | +11.25% | +22.49% | 641.87Cr | |
| -0.06% | -0.74% | -3.46% | +16.97% | 497.99Cr | |
| +1.56% | +2.49% | +11.06% | +17.71% | 361.95Cr | |
| Average | -0.38% | -0.64% | +4.23% | +54.65% | 2.2TCr | |
| Weighted average by Cap. | -0.66% | -1.31% | +25.46% | +120.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17TCr 2.52TCr 2.17TCr 2.04TCr 1.86TCr 3.49TCr 2,40800Cr 3.54TCr 24TCr 9.37TCr 1,20700Cr 9.46TCr 9.25TCr 4,01400Cr | 18TCr 2.65TCr 2.28TCr 2.14TCr 1.95TCr 3.67TCr 2,53000Cr 3.72TCr 25TCr 9.84TCr 1,26800Cr 9.93TCr 9.72TCr 4,21600Cr |
| Net income | 232.9Cr 35Cr 30Cr 28Cr 25Cr 48Cr 3.3TCr 49Cr 328.02Cr 128.54Cr 1.65TCr 129.71Cr 126.9Cr 5.51TCr | 251.71Cr 37Cr 32Cr 30Cr 28Cr 52Cr 3.57TCr 53Cr 354.52Cr 138.92Cr 1.79TCr 140.19Cr 137.15Cr 5.95TCr |
| Net Debt | -432.08Cr -64Cr -55Cr -52Cr -47Cr -89Cr -6.13TCr -90Cr -608.56Cr -238.47Cr -3.07TCr -240.65Cr -235.43Cr -10TCr | -504.29Cr -75Cr -65Cr -61Cr -55Cr -103.76Cr -7.15TCr -105.2Cr -710.26Cr -278.33Cr -3.58TCr -280.86Cr -274.78Cr -12TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | CN¥4.990 | -1.38% | 4,08,27,586 |
| 14/26/14 | CN¥5.060 | -0.59% | 2,69,36,681 |
| 13/26/13 | CN¥5.090 | +0.99% | 4,55,53,731 |
| 12/26/12 | CN¥5.040 | -0.59% | 4,36,55,619 |
| 11/26/11 | CN¥5.070 | +0.40% | 4,36,61,675 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
